Annexon's Interim Mid-Stage Results On Huntington's Disease Candidate Fails To Cheer
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
Neurocrine's Ingrezza Meets Primary Goal In Phase 3 Study In Patients With Involuntary Muscle Movement
Roche's Spark Therapeutics, NeuExcell Join Forces To Develop Huntington's Disease Gene Therapy
Huntington's Disease Recent News
DSMB Recommends UniQure To Continue Huntington's Gene Therapy Trial Unchanged
Voyager Therapeutics' Stock Jumps As FDA Lifts Clinical Hold For Huntington's Disease Gene Therapy
Wave Life Sciences Stock Plunges After Antisense Oligonucleotide Candidates Disappoint In Huntington's Disease Study
Ionis Pharma Stock Is Trading Lower After Roche Drops Huntington's Disease Trial With Tominersen
No Safety Concerns Observed In Uniqure's Early-Stage Huntington's Gene Therapy Study, DSMB Says
Janney: Buy The Dip In Uniqure